Talphera (TLPH) Projected to Post Earnings on Tuesday

Talphera (NASDAQ:TLPH) is anticipated to announce its Q1 2025 earnings results after the market closes on Tuesday, May 13th. Analysts expect Talphera to post earnings of ($0.17) per share for the quarter.

Talphera (NASDAQ:TLPH) last posted its quarterly earnings data on Monday, March 31st. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.14. On average, analysts expect Talphera to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Talphera Trading Down 2.0 %

NASDAQ:TLPH opened at $0.54 on Friday. Talphera has a 12-month low of $0.45 and a 12-month high of $1.27. The firm has a market cap of $9.23 million, a PE ratio of -0.78 and a beta of -0.15. The stock has a fifty day moving average price of $0.53 and a 200 day moving average price of $0.63.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on TLPH. Rodman & Renshaw started coverage on Talphera in a research report on Tuesday, January 28th. They set a “buy” rating and a $4.00 price objective for the company. RODMAN&RENSHAW upgraded shares of Talphera to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, HC Wainwright restated a “buy” rating and issued a $6.00 price target on shares of Talphera in a research note on Tuesday, April 1st.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.